General Information of DTT (ID: TTR93NU)

DTT Name Casein kinase II alpha prime (CSNK2A2) DTT Info
Gene Name CSNK2A2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Patented Agent(s)
Investigative Drug(s)
6 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
US8791257, 17 DMUPRX2 N. A. N. A. Patented [1]
US8791257, 38 DMAEHCP N. A. N. A. Patented [1]
US8791257, 4 DMIQO8N N. A. N. A. Patented [1]
US8940736, 23 DM3PU57 N. A. N. A. Patented [2]
US8940736, 6 DMXY4SP N. A. N. A. Patented [2]
US8940736, 7 DM9KSVI N. A. N. A. Patented [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Patented Agent(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID22115617C2c DMX5UKA Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Substituted pyrrolotriazines as protein kinase inhibitors. US8791257.
2 Imidazotriazinecarbonitriles useful as kinase inhibitors. US8940736.
3 CK2alpha and CK2alpha' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012 Jan;47(1):345-50.